KONKUK UNIVERSITY MEDICAL CENTER

Huonslab has completed patient enrollment in its pivotal Phase 1 clinical trial of HLB3-002 (Hydizyme™), a recombinant human hyaluronidase, with 243 healthy volunteers across four leading South Korean medical centers.

A Korean study found that nine weeks of Leclaza treatment can lower the stage of inoperable lung cancer patients with EGFR mutations, making them eligible for surgery.

A multi-center, double-blind, randomized trial is underway to compare ROTEM-guided tranexamic acid (TXA) administration with preemptive TXA in cardiovascular surgery patients.